Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC16A3 |
| Upstream (Parents) |
|---|
| (<<) ALAD → SLC16A3 |
| (<<) MAOB → SLC16A3 |
| (<<) ADAMTSL3 → SLC16A3 |
| (<<) FCHO1 → SLC16A3 |
| (<<) PPAP2B → SLC16A3 |
| (<<) HPS5 → SLC16A3 |
| Downstream (Children) |
|---|
| SLC16A3 → SEMA6D (>>) |
| SLC16A3 → THEG (>>) |
| SLC16A3 → PRR4///PRH2///PRH1///PRB4///PRB1 (>>) |
| SLC16A3 → C1orf61 (>>) |
| SLC16A3 → SSX2 (>>) |
| SLC16A3 → CLSPN (>>) |
| SLC16A3 → RGR (>>) |
| SLC16A3 → IFNA7 (>>) |
